These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20304710)

  • 61. Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.
    Newbold KL; Flux G; Wadsley J
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):307-309. PubMed ID: 28139379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.
    Bulotta S; Celano M; Costante G; Russo D
    Endocrine; 2016 May; 52(2):214-21. PubMed ID: 26690657
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.
    Campopiano MC; Ghirri A; Prete A; Lorusso L; Puleo L; Cappagli V; Agate L; Bottici V; Brogioni S; Gambale C; Minaldi E; Matrone A; Elisei R; Molinaro E
    Front Endocrinol (Lausanne); 2023; 14():1133958. PubMed ID: 37152950
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preparation for radioiodine therapy: how to increase therapeutic efficacy and accelerate unbound radioiodine excretion.
    Matović M
    Vojnosanit Pregl; 2013 May; 70(5):504-10. PubMed ID: 23789291
    [No Abstract]   [Full Text] [Related]  

  • 65. Phytochemicals in thyroid cancer: analysis of the preclinical studies.
    Bulotta S; Capriglione F; Celano M; Pecce V; Russo D; Maggisano V
    Endocrine; 2021 Jul; 73(1):8-15. PubMed ID: 33587255
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Age of menopause in patients with differentiated thyroid cancer treated with radioiodine].
    Manuel García-Quirós Muñoz J; Martín Hernández T; Torres Cuadro A; Cambil Molina T; Castro Montaño J; Sendón Pérez A
    Endocrinol Nutr; 2010 Mar; 57(3):105-9. PubMed ID: 20304710
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
    Börner AR; Müller-Gärtner HW
    Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of 131I in the treatment of well differentiated thyroid cancer.
    Woodrum DT; Gauger PG
    J Surg Oncol; 2005 Mar; 89(3):114-21. PubMed ID: 15719384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.